Safety and tolerability of mice to repeated subcutaneous injections of a peptide mix as a potential vaccine against HCV infection.

CONCLUSIONS: The extravagant histopathological changes in different organs have exiled the 16 μg dose out of acceptable range and validated that Cenv6 is safe and tolerable at the two lower doses (800 and 1600 ng/25 gm bw). PMID: 30594921 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30594921?dopt=Abstract

Source: Human Antibodies - January 1, 2019 Category: Biochemistry Tags: Hum Antibodies Source Type: research